SoftGroup took part in DSCSA Public Meeting held by FDA
SoftGroup was part of the FDA`s virtual public meeting regarding the implementation of the enhanced drug distribution security provisions of the DSCSA that go into effect in 2023.
On 16th November FDA held a virtual public meeting on enhanced drug distribution security at the package level. The purpose of this public meeting was to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to provide input to the FDA on the implementation of the enhanced drug distribution security provisions of the DSCSA that go into effect in 2023.
Our colleague Iordan Dunkov, Head of Strategic Partnerships and Initiatives, was part of the meeting and presented the topic in terms of our experience.
If you want to see the presentation, you could find the recording of the official meeting HERE.